Touyun Biotech Group (HKSE:01332) Inventories, Work In Process: HK$5.82 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

HKSE:01332 Touyun Biotech Group Ltd HKSE:01332
25 GF Score
Price HK$0.15
GF Value HK$0.16
Valuation Fairly Valued
! 6 Warning Signs
View Full Analysis

What is Touyun Biotech Group Inventories, Work In Process?

Touyun Biotech Group HKSE:01332 -3.80% 25 Inventories, Work In Process is HK$5.82 Mil as of Dec. 2025. GuruFocus rates HKSE:01332 with a GF Score™ of 25/100 and a GF Value™ of HK$0.16 (Fairly Valued). The stock has 6 warning signs investors should review.

Work in process is the part of a manufacturer's inventory that is in the production process and has not yet been completed and transferred to the finished goods inventory. Touyun Biotech Group's work in process for the quarter that ended in Dec. 2025 was HK$5.82 Mil.

Touyun Biotech Group Inventories, Work In Process Historical Data

* Premium members only.

The historical data trend for Touyun Biotech Group's Inventories, Work In Process can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Touyun Biotech Group Inventories, Work In Process Chart

Touyun Biotech Group Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Inventories, Work In Process
Get a 7-Day Free Trial Premium Member Only Premium Member Only 5.33 1.97 4.06 4.79 5.82

Touyun Biotech Group Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Inventories, Work In Process Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.06 0.00 4.79 0.00 5.82
HKSE:01332
25GF Score
Touyun Biotech Group Ltd HKSE:01332
Inventories, Work In Process is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Touyun Biotech Group Inventories, Work In Process Calculation

That part of a manufacturer's inventory that is in the production process and has not yet been completed and transferred to the finished goods inventory. This account contains the cost of the direct material, direct labor, and factory overhead placed into the products on the factory floor. A manufacturer must disclose in its financial statements the cost of its work-in-process as well as the cost of finished goods and materials on hand.

What does a Inventories, Work In Process of HK$5.82 Mil mean?
Touyun Biotech Group (HKSE:01332) has a Inventories, Work In Process of HK$5.82 Mil as of Dec. 2025. Work in progress is the portion of inventory containing goods that are unfinished. View historical data on Touyun Biotech Group and its competitors.
Is Touyun Biotech Group's Inventories, Work In Process too high?
Touyun Biotech Group's current Inventories, Work In Process is HK$5.82 Mil. Overall, Touyun Biotech Group has a GF Score™ of 25/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Touyun Biotech Group's Inventories, Work In Process compare to SW and PKG?
Touyun Biotech Group's Inventories, Work In Process of HK$5.82 Mil can be compared against companies in the Packaging & Containers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Inventories, Work In Process for a Packaging & Containers company?
A good Inventories, Work In Process depends on the Packaging & Containers industry context. However, Inventories, Work In Process should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Inventories, Work In Process mean?
A high Inventories, Work In Process can signal that a stock is expensive relative to its fundamentals. Work in progress is the portion of inventory containing goods that are unfinished. View historical data on Touyun Biotech Group and its competitors. Touyun Biotech Group's current Inventories, Work In Process is HK$5.82 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Touyun Biotech Group stock overvalued right now?
Based on GuruFocus' analysis, Touyun Biotech Group (HKSE:01332) is currently considered Fairly Valued. The stock's GF Value™ is HK$0.16, compared to a current price of HK$0.15 — trading 5% below its estimated fair value. The current Inventories, Work In Process is HK$5.82 Mil. Touyun Biotech Group's overall GF Score™ is 25/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Inventories, Work In Process calculated?
Inventories, Work In Process is calculated from a company's financial statements. For Touyun Biotech Group (HKSE:01332), the current Inventories, Work In Process is HK$5.82 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Touyun Biotech Group (HKSE:01332) Overvalued in 2026?

Based on GuruFocus' analysis, Touyun Biotech Group stock appears to be undervalued. The current stock price of HK$0.15 is trading 5% below its estimated GF Value™ of HK$0.16. GuruFocus considers Touyun Biotech Group to be Fairly Valued.

Key valuation signals for HKSE:01332:

  • Inventories, Work In Process: HK$5.82 Mil
  • GF Value™: HK$0.16 vs. price of HK$0.15 (5% below fair value)
  • GF Score™: 25/100 with 6 warning signs

No single metric tells the full story. See the HKSE:01332 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Touyun Biotech Group Business Description

Address 6 Tonnochy Road, 12th Floor, Kwan Chart Tower, Wanchai, Hong Kong, HKG
Touyun Biotech Group Ltd is principally engaged in the (i) the manufacture and sale of packaging products; (ii) investments and trading in securities and money lending, and (iii) production and sale of Chlamydomonas reinhardtii, micro-algae and related products. The company generates majority of its revenue from packaging products segment.
25GF Score

Get the complete analysis for HKSE:01332

Inventories, Work In Process is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

HK$0.15
Price
HK$0.16
GF Value